Depomed (DEPO) Misses Q1 EPS by 7c; Guides Below
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
DepoMed Inc (DEPO) PT Lowered to $13 at RBC Capital; Magnitude of Reset was a Suprise
May 10, 2017 6:24 AM EDTRBC Capital lowered its price target on DepoMed Inc (NASDAQ: DEPO) to $13.00 (from $19.00) while maintaining a Sector Perform rating following a sizable reset on outlook.
Analyst Randall Stanicky said the reset is not a surprise given new CEO but magnitude... More
Piper Jaffray Upgrades DepoMed Inc (DEPO) to Neutral
May 10, 2017 4:54 AM EDTPiper Jaffray upgraded DepoMed Inc (NASDAQ: DEPO) from Underweight to Neutral with a price target of $10.00 (from $11.00).
Analyst David Amsellem believes the company multiple is reflective of the company's "relatively murky prospects" when it comes to LT growth opportunities.
FY 2017 EPS estimate... More
